<SEC-DOCUMENT>0001683168-17-001164.txt : 20170511
<SEC-HEADER>0001683168-17-001164.hdr.sgml : 20170511
<ACCEPTANCE-DATETIME>20170510190829
ACCESSION NUMBER:		0001683168-17-001164
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20170510
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170511
DATE AS OF CHANGE:		20170510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		17831970

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>radnet_8k-051017.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0pt 0"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>



<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported
May 10, 2017)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RADNET, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; text-align: center">Delaware</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 34%; text-align: center">001-33307</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; text-align: center">13-3326724</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(State or Other Jurisdiction of Incorporation)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Commission File Number)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(IRS Employer Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">1510 Cotner
Avenue </FONT><BR></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">Los Angeles, California 90025</FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal">(Address of Principal Executive Offices) (Zip Code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(310)&nbsp;478-7808<BR>
<FONT STYLE="font-size: 10pt">(Registrant&rsquo;s Telephone Number, Including Area Code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[_] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[_] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[_] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b) )</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[_] Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c) )</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.&nbsp; <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"></TD><TD></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in">Item 2.02</TD><TD>RESULTS OF OPERATIONS AND FINANCIAL CONDITION</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 10, 2017 RadNet,
Inc. (&ldquo;RadNet&rdquo;) issued a press release and held a conference call regarding our financial results for the quarter ended
March 31, 2017. A copy of the press release is furnished as Exhibit 99.1 and a copy of the transcript of the conference call is
furnished as Exhibit 99.2 to this Current Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in
this Current Report, including Exhibit 99.1 and Exhibit 99.2 is being furnished and shall not be deemed &ldquo;filed&rdquo; for
purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information
in this Current Report, including Exhibit 99.1 and Exhibit 99.2 shall not be incorporated by reference into any registration statement
or other document filed with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 9.01</B></TD><TD STYLE="text-align: justify"><B>FINANCIAL STATEMENTS AND EXHIBITS.</B></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 12%; border-bottom: Black 1pt solid">Exhibit Number</TD>
    <TD STYLE="width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 86%; border-bottom: Black 1pt solid">Description
of Exhibit</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>99.1<FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Press Release dated May 10, 2017 relating to RadNet, Inc.&rsquo;s financial results for the quarter ended March 31, 2017.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>99.2<FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Transcript of conference call.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">SIGNATURE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">Date:&nbsp;&nbsp;May 10, 2017</TD>
    <TD STYLE="width: 50%; text-align: left"><B>RADNET, INC.</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">By:
        <U>/s/ Jeffrey L. Linden&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">Name: Jeffrey L. Linden<BR>
        Title: Executive Vice President and General Counsel</P></TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT INDEX</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 12%; border-bottom: Black 1pt solid"><B>Exhibit Number</B></TD>
    <TD STYLE="width: 2%; padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD STYLE="width: 86%; border-bottom: Black 1pt solid"><B>Description of Exhibit</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><B>99.1</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD><B>Press Release dated May 10, 2017.</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><B>99.2</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD><B>Transcript of conference call.</B></TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>radnet_8k-ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Exhibit 99.1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 98px; width: 230px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR IMMEDIATE RELEASE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><B>RadNet Reports First Quarter Financial Results and Reaffirms
2017 Guidance Ranges</B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Total Net Revenue (&ldquo;Revenue&rdquo;) increased 5.8% to $229.0
million in the first quarter of 2017 from $216.4 million in the first quarter of 2016</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Adjusted EBITDA<SUP>(1)</SUP> increased 5.8% to $28.7 in the first
quarter of 2017 from $27.1 million in the first quarter of 2016 </I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Diluted loss per share was $(0.03) per share in the first quarter
of 2017, flat from the prior year&rsquo;s first quarter</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; color: windowtext"><I>Aggregate procedural volumes increased 2.5%
and same center volumes increased </I></FONT><I><FONT STYLE="font-family: Times New Roman, Times, Serif">2.1<FONT STYLE="color: windowtext">%
as compared with the first quarter of 2016</FONT></FONT></I></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Established two joint ventures with Cedars-Sinai in the greater
Los Angeles area</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Exited the Rhode Island marketplace through the sale of its five
imaging centers</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>LOS ANGELES, California, May 10, 2017
&ndash; RadNet, Inc. (NASDAQ: RDNT),</B> <FONT STYLE="color: black">a national leader in providing high-quality, cost-effective,
fixed-site outpatient diagnostic imaging services through a network of 303 owned and/or operated outpatient imaging centers</FONT>,
today reported financial results for its first quarter of 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief
Executive Officer of RadNet, commented, &ldquo;I&rsquo;m very pleased with the improvement of our base imaging center business
in this first quarter as compared with last year&rsquo;s first quarter, particularly when adjusting for year-over-year changes
in two items that more favorably benefited last year&rsquo;s first quarter. In the first quarter of last year, we recognized $2.8
million of Other Income from Meaningful Use incentives as a result of our adoption of eRAD software and $825,000 of Revenue from
our management contract in the sovereign nation of Qatar. In this year&rsquo;s first quarter, we recognized only $600,000, combined,
for these two sources. Adjusting both quarters by removing contributions from Meaningful Use and Qatar activities, Revenue from
core operations increased 6.1% in this year&rsquo;s first quarter and EBITDA increased 19.5%.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;The performance of our imaging business
is benefiting from a number of factors. First, our investment in new technologies is beginning to pay dividends, especially 3D
digital mammography &ndash; which is now being reimbursed by many of the large national payors in addition to Medicare. Second,
our performance benefited from successful pricing negotiations with private payors in several of our regions and with a number
of our capitated medical groups. Third, we continue to effectively control and reduce expenses. Lastly, we are experiencing continuing
improvement in our New York City marketplace from the integration of our acquisitions of New York Radiology Partners and Diagnostic
Imaging Group,&rdquo; added Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the first quarter of 2017, RadNet reported
Revenue of $229.0 million, Adjusted EBITDA<SUP>(1)</SUP> of $28.7 million and Net Loss of $1.2 million. Revenue increased $12.6
million (or 5.8%), Adjusted EBITDA<SUP>(1)</SUP> increased $1.6 million (or 5.8%) and Net Loss decreased $187,000, over the first
quarter of 2016. Per share <FONT STYLE="color: black">Net Loss for the first quarter was $(0.03), compared to the same in the first
quarter of 2016, based upon a weighted average number of basic and diluted shares outstanding of 46.6 million for both periods
in 2017 and 2016.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: black">Affecting Net
Loss in the first quarter of 2017 were certain non-cash expenses and non-recurring items including: $3.3 million of non-cash employee
stock compensation expense resulting from the vesting of certain options and restricted stock; </FONT>$203,000 of severance paid
in connection with headcount reductions related to cost savings initiatives; and <FONT STYLE="color: black">$814,000 of combined
non-cash amortization of deferred financing costs and loan discounts related to financing fees paid as part of our existing credit
facilities. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the first quarter of 2017, as compared
to the prior year&rsquo;s first quarter, MRI volume increased 5.1%, CT volume increased 6.0% and PET/CT volume increased 5.7%.
Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased
2.5% over the prior year&rsquo;s first quarter. On a same-center basis, including only those centers which were part of RadNet
for both the first quarters of 2017 and 2016, MRI volume increased 3.3%, CT volume increased 4.4% and PET/CT volume increased 5.7%.
Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams,
increased 2.1% over the prior year&rsquo;s same quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to the end of the quarter, on
April 1<SUP>st</SUP>, RadNet established two imaging joint ventures with Cedars-Sinai, one of the premier academic medical centers
in the country. The joint venture agreement in Santa Monica consists initially of one multi-modality imaging center (Resolution
Imaging), which was contributed to the joint venture by RadNet. Under the terms of the joint venture in the San Fernando Valley,
Cedars-Sinai has purchased an interest in four imaging centers previously owned by RadNet. RadNet will continue to manage the operations
of the imaging centers of both joint ventures on a day-to-day basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, subsequent to quarter end,
on April 1<SUP>st</SUP>, RadNet sold the assets of its five locations in Rhode Island comprising The Imaging Institute to a strategic
buyer for $5.0 million. The five centers were originally part of RadNet&rsquo;s acquisition completed in November 2011 of the United
States operations of CML Healthcare. The divestiture is consistent with RadNet&rsquo;s core operating strategy of being the leading
outpatient imaging provider in all the geographies in which it operates. It was concluded that these Rhode Island assets were better
suited under the ownership of another local operator who seeks to aggressively expand its presence in that marketplace.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>2017 Guidance Update</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RadNet reaffirms its previously announced
2017 guidance ranges as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Total Net Revenue</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">$895 million - $925 million</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Adjusted EBITDA<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">$135 million - $145 million</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Capital Expenditures (a)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">$55 million - $60 million</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Cash Interest Expense</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">$35 million - $40 million</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Free Cash Flow Generation (b)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">$40 million - $50 million</P></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="width: 47%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">Net of proceeds from the sale of equipment, imaging centers and joint venture interests.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">Defined by the Company as Adjusted EBITDA<SUP>(1)</SUP> less total capital expenditures and cash
paid for interest.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger highlighted, &ldquo;We remain
confident about our previously announced guidance levels. When we set our guidance levels upon the release of our fourth quarter
2016 earnings, we incorporated normal seasonality that we experience in our business. This seasonality considers the typical front-loading
of our capital spending in the first half of the year and lower first quarter Revenue and profitability from weaker utilization
of services as a result of winter weather on the east coast and from patients in high deductible programs seeking to avoid or delay
services. Comparing the first quarter results with our internal projections, we are on track to meet our objectives for the year.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Conference Call for Today</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief
Executive Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss
its first quarter 2017 results on Wednesday, May 10th, 2017 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Conference Call Details:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: Wednesday, May 10, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Time: 10:30 a.m. Eastern Time</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dial In-Number: 888-596-2573</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">International Dial-In Number: 913-312-0379</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is recommended that participants dial
in approximately 5 to 10 minutes prior to the start of the 10:30 a.m. call. There will also be simultaneous and archived webcasts
available at <FONT STYLE="font-family: Times New Roman, Times, Serif; color: #2F82DE"><B>http://public.viavid.com/index.php?id=124224</B></FONT>
or http://www.radnet.com under the &ldquo;Investors&rdquo; menu section and &ldquo;News Releases&rdquo; sub-menu of the website.
An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671
for international callers, and using the passcode 3102466.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Regulation G: GAAP and Non-GAAP Financial
Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This release contains certain financial
information not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results.
The Company believes that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance.
The Company believes this information is useful to investors and other interested parties because it removes unusual and nonrecurring
charges that occur in the affected period and provides a basis for measuring the Company's financial condition against other quarters.
Such information should not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable
to other similarly titled measures of other companies. Non-GAAP financial measures should not be considered in isolation from,
or as a substitute for, financial information prepared in accordance with GAAP. Reconciliation of this information to the most
comparable GAAP measures is included in this release in the tables which follow.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>About RadNet, Inc.</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">RadNet, Inc. is the leading national provider
of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging
revenue. RadNet has a network of 303 owned and/or operated outpatient imaging centers. RadNet's core markets include California,
Maryland, Delaware, New Jersey and New York. In addition, RadNet provides radiology information technology solutions, teleradiology
professional services and other related products and services to customers in the diagnostic imaging industry. Together with affiliated
radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has a total of approximately 7,300 employees.
For more information, visit http://www.radnet.com.</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>Forward Looking Statements</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This press release contains forward-looking
statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning
successfully integrating acquired operations, successfully achieving 2017 financial guidance, successfully developing and integrating
new lines of business, continuing to grow its business by generating patient referrals and contracts with radiology practices,
and receiving third-party reimbursement for diagnostic imaging services, are forward-looking statements within the meaning of the
Safe Harbor. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and
uncertainties, which may cause the Company's actual results to differ materially from the statements contained herein. Further
information on potential risk factors that could affect RadNet's business and its financial results are detailed in its most recent
Annual Report on Form 10-K, as filed with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking
statements, especially guidance on future financial performance, which speaks only as of the date they are made. RadNet undertakes
no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date
they were made, or to reflect the occurrence of unanticipated events.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>CONTACTS:</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>RadNet, Inc.</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mark Stolper, 310-445-2800</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Executive Vice President and Chief
Financial Officer</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED BALANCE SHEETS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS
EXCEPT SHARE AND PER SHARE DATA)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">March 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="4" STYLE="font-weight: bold; text-align: center">ASSETS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="4" STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 66%; text-align: left; padding-left: 10pt">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">8,294</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">20,638</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">169,538</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">164,210</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Due from affiliates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,122</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,428</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Prepaid expenses and other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,635</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,435</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Assets held for sale</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,851</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,203</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 30pt">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">208,440</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">217,914</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">PROPERTY AND EQUIPMENT, NET</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">257,458</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">247,725</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OTHER ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">239,954</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">239,553</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Other intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,132</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,682</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Deferred financing costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,919</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,004</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Investment in joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46,114</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,509</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Deferred tax assets, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">51,446</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,356</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Deposits and other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,519</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,733</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 30pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">853,982</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">849,476</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 30pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="4" STYLE="font-weight: bold; text-align: center">LIABILITIES AND EQUITY</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD COLSPAN="4" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts payable, accrued expenses and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">113,729</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">111,166</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Due to affiliates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,786</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,141</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,574</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,516</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Current portion of deferred rent</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,961</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Current portion of notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,016</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,031</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Current portion of obligations under capital leases</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,826</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,526</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 30pt">Total current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">158,928</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">155,341</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">LONG-TERM LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Deferred rent, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,739</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,799</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Notes payable, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">603,404</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">609,445</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Obligations under capital lease, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,606</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,730</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other non-current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,197</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,108</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 30pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">800,874</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">797,423</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">RadNet, Inc. stockholders' equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 22pt; text-indent: -11pt">Common stock - $.0001 par value, 200,000,000 shares authorized; 47,216,929, and 46,574,904 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Additional paid-in-capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">201,563</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">198,387</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accumulated other comprehensive (loss) gain</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(470</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">306</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(151,421</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(150,211</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Total RadNet, Inc.'s stockholders' equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,676</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,486</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,432</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,567</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 30pt">Total equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">53,108</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">52,053</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 30pt">Total liabilities and equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">853,982</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">849,476</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE DATA)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center">Three Months Ended</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31,</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">NET REVENUE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 66%; text-align: left; padding-left: 20pt">Service fee revenue, net of contractual allowances and discounts</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">212,750</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">200,842</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Provision for bad debts</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(11,646</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(10,304</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Net service fee revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">201,104</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">190,538</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Revenue under capitation arrangements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">27,909</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">25,850</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 33pt">Total net revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">229,013</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">216,388</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Cost of operations, excluding depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">205,454</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">196,826</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 20pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,654</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,412</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Gain on sale and disposal of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(45</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Severance costs</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">203</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">167</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 33pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">222,266</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">213,405</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">INCOME FROM OPERATIONS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,747</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,983</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OTHER INCOME AND EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,240</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,681</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 20pt">Meaningful use incentive</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(250</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,808</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,928</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,279</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Other expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 33pt">Total other expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,065</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,596</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">LOSS BEFORE INCOME TAXES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,318</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,613</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Benefit from income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">458</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,506</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">NET LOSS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(860</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,107</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Net income attributable to noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">350</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">290</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">NET LOSS ATTRIBUTABLE TO RADNET, INC.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,210</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,397</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">BASIC AND DILUTED LOSS PER SHARE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.03</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.03</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 20pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold">DILUTED NET INCOME PER SHARE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.03</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.03</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 20pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Basic and Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">46,560,017</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">46,581,491</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 20pt">Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">46,560,017</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">46,581,491</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended March 31,</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;CASH FLOWS FROM OPERATING ACTIVITIES</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; text-align: left; padding-left: 10pt">Net loss</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">(860</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">(1,107</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Adjustments to reconcile net loss to net cash provided by operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,654</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,412</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Provision for bad debts</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,646</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,304</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,928</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,279</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Distributions from joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,323</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,038</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Amortization of deferred financing costs and loan discount</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">814</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,368</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Gain on sale and disposal of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(45</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Stock-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,276</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,733</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 22pt; text-indent: -11pt">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 30pt">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(16,974</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(25,291</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 30pt">Other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,043</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,288</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 30pt">Other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">856</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 30pt">Deferred taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,090</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,612</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 30pt">Deferred rent</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,976</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">443</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 30pt">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(70</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 30pt">Accounts payable, accrued expenses and other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10,995</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,880</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 40pt">Net cash provided by operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">30,896</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">20,963</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Purchase of imaging facilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,154</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,007</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Investments at cost</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(500</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Purchase of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(30,371</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(22,500</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Proceeds from sale of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">59</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Equity contributions in existing joint ventures</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(294</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 40pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(33,966</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(27,801</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Principal payments on notes and leases payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,158</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,166</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Payments on Term Loan Debt/Senior Notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,063</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,178</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Deferred financing costs and debt discount</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(570</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Proceeds on revolving credit facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">105,100</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">126,200</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Payments on revolving credit facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(105,100</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(109,900</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Dividends paid to noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(485</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(158</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 40pt">Net cash (used in) provided by financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(9,276</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,798</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">EFFECT OF EXCHANGE RATE CHANGES ON CASH</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">NET DECREASE IN CASH AND CASH EQUIVALENTS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,344</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(36</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">CASH AND CASH EQUIVALENTS, beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">20,638</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">446</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">CASH AND CASH EQUIVALENTS, end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">8,294</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">410</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Cash paid during the period for interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">11,035</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">9,085</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: left; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white"><B>RADNET,
INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white"><B>RECONCILIATION
OF GAAP NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white"><B>COMMON SHAREHOLDERS TO ADJUSTED EBITDA<SUP>(1)</SUP></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>(IN THOUSANDS)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">Three Months Ended</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid">March 31,</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; text-align: left">Net Loss Attributable to RadNet, Inc. Common Shareholders</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">(1,210</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">(1,397</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Less Benefit From Income Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(458</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,506</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Other Expenses (Income)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Interest Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,240</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,681</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Severance Costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">203</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">167</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Less Gain on Sale of Equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(45</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Depreciation and Amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,654</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,412</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Plus Non Cash Employee Stock Compensation</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,276</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,733</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; font-style: normal; padding-bottom: 2.5pt; padding-left: 44pt"><B>Adjusted EBITDA<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><SUP>(1)</SUP></FONT></B></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">28,663</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">27,092</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B></B></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">PAYOR CLASS
BREAKDOWN**</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 50%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">First Quarter</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 34%; text-align: left">Commercial Insurance</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">58.6%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Medicare</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19.8%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Capitation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.6%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Workers Compensation/Personal Injury</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.8%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Medicaid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.8%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3.4%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">100.0%</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">**Capitation percentage has been calculated based upon its proportion of Revenue Under Capitation Arrangements in the period&nbsp;&nbsp;to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Service Fee Revenue, Net of Contractual Allowances and Discounts plus Revenue Under Capitation Arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">After deducting the capitation percentage from 100%, all other payor class percentages are based upon a proportion to global payments</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">received from consolidated imaging centers from that periods dates of services and excludes payments</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">from hospital contracts, Breastlink, imaging center management fees, eRAD, Imaging on Call and other miscellaneous revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><BR CLEAR="ALL"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET PAYMENTS
BY MODALITY *</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">First Quarter</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2014</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%">MRI</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">35.0%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">34.7%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">35.3%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">36.1%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.3%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.8%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.7%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.3%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>PET/CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.1%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.1%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.7%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>X-ray</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.3%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.3%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.6%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.2%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Ultrasound</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.2%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.3%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.5%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.1%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Mammography</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.8%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.5%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.4%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.5%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Nuclear Medicine</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.2%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.2%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.3%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.4%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5.1%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5.2%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5.1%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3.7%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; margin-top: 0pt; margin-bottom: 0pt">Note</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">* Based upon global payments received from consolidated Imaging Centers from that year's dates of service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Excludes payments from hospital contracts, Breastlink, Imaging on Call, eRAD, Center Management Fees and other miscellaneous operating activities.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><BR CLEAR="ALL">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Footnotes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: windowtext">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: windowtext"><SUP>(1)</SUP>
The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations
and adjusted for losses or gains on the sale of equipment, other income or loss, debt extinguishments and non-cash equity compensation.
Adjusted EBITDA</FONT> includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling
interests in subsidiaries<FONT STYLE="color: windowtext">, and is adjusted for non-cash or extraordinary and one-time events taken
place during the period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: windowtext">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted EBITDA is reconciled to its nearest
comparable GAAP financial measure. Adjusted EBITDA is a non-GAAP financial measure used as analytical indicator by RadNet management
and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt.
Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA
should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing
activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance
or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying
methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: windowtext"><SUP>(2)</SUP>
As noted above, the Company defines Free Cash Flow as </FONT>Adjusted EBITDA less total Capital Expenditures (whether completed
with cash or financed) and Cash Interest paid. <FONT STYLE="color: windowtext">Free Cash Flow is a non-GAAP financial measure.
</FONT>The Company uses Free Cash Flow because the Company believes it provides useful information for investors and management
because it measures our capacity to generate cash from our operating activities. Free Cash Flow does not represent total cash flow
since it does not include the cash flows generated by or used in financing activities. In addition, our definition of Free Cash
Flow may differ from definitions used by other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Free Cash Flow should not be considered
a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation
or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement
data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA
is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric,
as presented, may not be comparable to other similarly titled measures of other companies.</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>radnet_8k-ex9902.htm
<DESCRIPTION>CONFERENCE CALL TRANSCRIPT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"><IMG SRC="image_003.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00339A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00339A"><B>C O R P O R A T E P A R
T I C I P A N T S</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper, </B><I>Executive Vice
President and Chief Financial Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D., </B><I>President
and Chief Executive Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>C O N F E R E N C E
C A L L P A R T I C I P A N T S</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut, </B><I>Jefferies &amp;
Company, Inc.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal, </B><I>Sidoti &amp;
Company, LLC</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Edward Kressler, </B><I>Angelo, Gordon
&amp; Co.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>P R E S E N T A T I
O N</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good day, ladies and gentlemen, and welcome
to the RadNet, Inc. First Quarter 2017 Financial Results Conference Call. Today&rsquo;s conference is being recorded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I would like to turn conference
over to Mr. Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, Inc. Please go ahead, Sir.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. Good morning, ladies and gentlemen,
and thank you for joining Dr. Howard Berger and me today to discuss RadNet&rsquo;s first quarter 2017 financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before we begin today, we&rsquo;d like
to remind everyone of the Safe Harbor statement under the Private Securities Litigation Reform Act of 1995. This presentation contains
forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements
concerning anticipated future financial and operating performance, RadNet&rsquo;s ability to continue to grow the business by generating
patient referrals and contracts with radiology practices, recruiting and retaining technologists, receiving third-party reimbursement
for diagnostic imaging services, successfully integrating acquired operations, generating revenue and Adjusted EBITDA for the acquired
operations as estimated, among others, are forward-looking statements within the meaning of the Safe Harbor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward-looking statements are based on
Management&rsquo;s current preliminary expectations and are subject to risks and uncertainties which may cause RadNet&rsquo;s actual
results to differ materially from the statements contained herein. These risks and uncertainties include those risks set forth
in RadNet&rsquo;s reports filed with the SEC from time to time, including RadNet&rsquo;s Annual Report on Form 10-K for the year
ended December 31, 2016, and RadNet's quarterly report on Form 10-Q to be filed shortly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Undue reliance should not be placed on
forward-looking statements, especially guidance on future financial performance, which speaks only as of the date it is made. RadNet
undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances
after the date they were made, or to reflect the occurrences of unanticipated events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that, I&rsquo;d like to turn the call
over to Dr. Howard Berger, President and Chief Executive Officer of RadNet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark. Good morning, everyone,
and thank you for joining us today. On today&rsquo;s call, Mark and I plan to provide you with highlights from our first quarter
2017 results, give you more insight into factors which affected this performance, and discuss our future strategy. After our prepared
remarks, we will open the call to your questions. I&rsquo;d like to thank all of you for your interest in our Company and for dedicating
a portion of your day to participate in our conference call this morning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I am very encouraged about our results
this quarter. I believe it is a strong start to the year and our performance is in line with our 2017 internal projections. Our
first quarter, because of the normal seasonality in our business, is typically our slowest quarter from a patient volume standpoint,
and because a majority of our operating quotas (phon) are fixed, the fist quarters' EBITDA and profitability are generally more
challenged. Despite this, our metrics improved nicely relative to the first quarter of last year, and our improvement was primarily
from Same-Center gains.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we have not made any significant acquisitions
since the last quarter of 2015, our revenue increased 5.8% as a result of a combination of strong aggregate and Same-Center volume
performance, as well as pricing increases. Aggregate volumes increased 2.5% relative to last year's first quarter. The increased
volumes were particularly notable in our West Coast operations where total volumes increased 5% from the prior year's first quarter.
Although East Coast volumes also increased, these increases were more modest and were negatively impacted by a severe snowstorm
in the middle of March.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the pricing side, we received increases
in several of our markets from private payors. We are seeking more and more of the health plans with whom we contract, value these
savings they receive, when outpatient imaging is directed into freestanding, non-hospital-based facilities like ours. We are gratified
that these payors are willing to acknowledge the importance that we play within their provider networks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also driving Same-Center revenue performance
was growth in the enrollment and pricing increases within our capitated contracts, which contributed to the over $2 million increase
in our revenue under capitation agreements, quarter-over-quarter over prior year's same quarter. Revenue also increased from the
continued implementation of 3-D breast imaging or tomography, where today a little over a third of our digital mammography systems
have this capability. RadNet's implementation of 3-D imaging has been more accelerated on the East Coast where about 50% of our
mammography systems have this capability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3-D mammography is now being reimbursed
by most of the large national payors, in addition to Medicare. We are finding that even in situations where patient health plans
do not yet reimburse for the 3-D portion of a mammography exam, many of our patients are choosing to pay out-of-pocket in order
to get tomography. I believe, as breast 3-D tomography becomes even more accepted by referring physicians and patients, RadNet
will have further opportunity to capitalize on the enhanced revenue opportunity that 3-D breast imaging provides.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to our EBITDA performance,
during last year's first quarter, our EBITDA was aided by approximately $3.6 million of revenue and other income from our Qatar
Management Services Agreement and meaningful use incentives we received as a result of the adoption of our eRAD software system.
By comparison, during this year's first quarter, these two items total only $600,000. For comparison purposes, upon removing these
items from both quarters, the EBITDA of our base imaging and related operations grew 19.5% quarter over prior year's quarter, which
increased the EBITDA margin by a 137 basis points.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the pricing and procedural
volume increases I already discussed, the strong EBITDA improvement was driven by effective control of our cross and by continuing
improvement in our New York marketplace as a result of our integration of the three large acquisitions we made beginning in 2013
with Lenox Hill Radiology and in 2015 with the purchase of New York Radiology Partners and Diagnostic Imaging Group. The integration
among these three groups has been a substantial undertaking. In less than four years we have gone from having no imaging centers
or infrastructure in Manhattan and the surrounding boroughs to having almost 40 centers there currently.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As much of the integration has now been
completed in this market, I remain excited about further opportunities to expand in the greater New York City area which includes
acquisition possibilities, the potential for capitation with local medical groups and payors, hospital and health system partnerships.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As I discussed in our year-end financial
results call, we launched the platform of our Breastlink program in Manhattan on April 1. We have contracted for the services of
three well-known breast surgeons and one plastic surgeon located in the Columbus Circle area of Manhattan, which is co-located
with one of our advanced imaging centers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On average, 5 out of every 1,000 women
utilizing screening mammography will result in breast cancer that must be treated. We are currently seeing over 250,000 women each
year for mammograms in our New York City and Rockland County regions. Our plan is to attract a large portion of these women within
our Breastlink operation, and we look forward to updating you on our progress with Breastlink New York as the year progresses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From a strategic standpoint, we continue
to pursue health system partnerships, a model that has been extremely beneficial for us in the past, particularly on the East Coast,
where we have almost 15 established joint ventures. Last year in June, we established our first significant West Coast joint venture
in Glendale, California, with Dignity Health. On April 1 of this year, we established two imaging joint ventures with Cedars-Sinai
in the Santa Monica, California and San Fernando Valley region of Los Angeles. We are excited to partner with Cedars as it is one
of the premier academic medical institutions in the country and has extensive outreach and breadth of capabilities that are expanding
across the greater Los Angeles area. RadNet will continue to manage the operation of these imaging ventures on a day-to-day basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are engaged in a variety of conversations
for new joint ventures with health systems on both coasts, both with existing partners to expand our current relationships, and
with new partners. I believe these discussions, if they result in new partnerships, could have a material effect on some of our
local market strategies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Some of you have also seen in our financial
results press release this morning that we have exited the Rhode Island marketplace. As you may recall, we began operations in
Rhode Island in 2011 as part of the acquisition of the U.S. operations of CML Healthcare in Canada. We were most interested in
the CML assets in Maryland which, at the time, represented our largest competitor. Although we were intrigued about opportunities
in the Rhode Island marketplace, those assets did not fit well with the overall RadNet strategy. We were unable to build enough
scale there to be a meaningful player in that market. Thus, we determined that the centers were better off and more valuable in
the hands of another strategic operator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I'd like to turn the call
back over to Mark to discuss some of the highlights of our first quarter 2017 performance. When he is finished, I will make some
closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark
D. Stolper:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Howard. I'm now going to briefly
review our first quarter 2017 performance and attempt to highlight what I believe to be some material items. I will also give some
further explanation for certain items in our financial statements, as well as provide some insights into some of the metrics that
drove our first quarter performance. Lastly, I will reaffirm 2017 financial guidance levels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In my discussion, I will use the term Adjusted
EBITDA, which is a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation,
and amortization, each from continuing operations, and excludes losses or gains on the disposal of equipment, other income or loss,
loss on debt extinguishments, bargain purchase gains, and non-cash equity compensation. Adjusted EBITDA includes equity earnings
in unconsolidated operations and subtracts allocations of earnings to non-controlling interest in subsidiaries, and is adjusted
for non-cash or extraordinary and one-time events taking place during the period. A full quantitative reconciliation of Adjusted
EBITDA to net income or loss attributable to RadNet Inc. common Shareholders is included in our earnings release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that said, I'd now like to review
our first quarter 2017 results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three-months ended March 31, 2017,
RadNet reported revenue and Adjusted EBITDA of $229 million and $28.7 million respectively. Revenue increased $12.6 million or
5.8% over the prior-year same quarter and Adjusted EBITDA increased $1.6 million or 5.8% over the prior-year same quarter. Revenue
increased from a combination of volume and pricing growth relative to last year's first quarter, aggregate procedural volumes rose
2.5% while Same-Center volumes rose 2.1%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As discussed earlier by Dr. Berger, also
contributing to the increase in revenue were pricing increases we received in several of our markets, as well as increases in enrollment
and pricing in certain capitated contracts. As Dr. Berger discussed in his remarks, with respect to our EBITDA performance, during
last year's first quarter, our EBITDA was aided by approximately $3.6 million of revenue and other income from our Qatar Management
Service Agreement and meaningful use incentives we received as a result of the adoption of our eRAD software system. By comparison,
during this year's first quarter, these two items totaled only $600,000. Removing these items from both quarters, the EBITDA of
our base imaging business and related operations grew 19.5% over prior year's quarter. This is an increase of EBITDA margin of
137 basis points.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the first quarter of 2017 we performed
1,534,243 total procedures. The procedures were consistent with our multimodality approach whereby 77.4% of all the work we did
by volume was from routine imaging. Our procedures in the first quarter of 2017 were as follows: 192,627 MRIs as compared with
183,254 MRIs in the first quarter of 2016; 147,763 CTs as compared with 139,451 CTs in the first quarter of 2016; 6,855 PET CTs
as compared with 6,484 PET CTs in the first quarter of 2016; and 1,186,998 routine imaging exams which include nuclear medicine,
ultrasound, mammography, x-ray and all other exams as compared with 1,167,720 of all these exams in the first quarter of 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net loss for the first quarter of 2017
was $1.2 million, or negative $0.03 per share compared to a net loss of $1.4 million or negative $0.03 per share reported for the
three-month period ended March 31, 2016. This is based upon a weighted average number of shares outstanding of $46.6 million for
both of these periods in 2017 and '16.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Affecting net loss in the first quarter
of 2017 were certain non-cash expenses and nonrecurring items, including the following: $3.3 million of non-cash employee stock
compensation expense resulting from the vesting of certain options and restrictive stock; $203,000 of severance paid in connection
with headcount reductions related to cost savings initiatives; $814,000 of combined non-cash amortization of deferred financing
costs and loan discounts related to the financing fees paid as part of our existing credit facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to some specific income statement
accounts, overall, GAAP interest expense for the first quarter of 2017 was $10.2 million. This compares with GAAP interest expense
in the first quarter of 2016 of $10.7 million. Cash paid during the period for interest was $11 million as compared to $9.1 million
in last year's first quarter. For the first quarter of 2016, bad debt expense was 5.5% of our service fee revenue net of contractual
allowances and discounts compared to 5.1% for the first quarter of 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At March 31, 2017, after giving effect
to bond and term loan discounts, we had $627.6 million of net debt, which is total debt less our cash balance, but we were undrawn
on our revolving $117.5 million line of credit. At March 31, 2017, our accounts receivable balance was $169.5 million, an increase
of $5.3 million from year-end 2016. The increase in accounts receivable is mainly from increased patient volume towards the end
of the first quarter where payments were not received as of March 31.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our DSO, or Days Sales Outstanding, was
59.2 days at March 31, 2017, which is down from 61.2 days at year-end 2016. During the quarter, we repaid $8.2 million of notes
and leases payable and term loan debt, and had cash capital expenditures net of dispositions of $30.3 million, and purchased equipment
on capital leases of approximately $5.2 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I'd like to reaffirm our
2017 Fiscal Year guidance levels, which we released in conjunction with our fourth quarter and year-end 2016 financial results.
For total net revenue, our guidance level is $895 million to $925 million; Adjusted EBITDA, our guidance level is $135 million
to $145 million; capital expenditures, our guidance level is $55 million to $60 million; our cash interest expense, our guidance
level is $35 million to $40 million; and for free cash flow generation, our guidance level is $40 million to $50 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to Medicare reimbursement
for 2018, there is nothing yet to report at this time. As is typical each year, we are expecting CMS to release a preliminary rate
schedule sometime in June or July, at which time we will analyze CMS's proposal and our industry's lobbying group, the Association
for Quality Imaging, of which Steve Forthuber, RadNet's East Coast Chief Operating Officer, is the Chairman. We'll provide CMS
our industry's feedback. At the time of our second quarter financial results call, we will be in a position to comment on CMS's
proposal and its impact, if any, upon RadNet's future results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I'd now like to turn the call back to Dr.
Berger who will make some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark. In the coming quarters
we expect that much of our focus will be on continuing to improve our operations, pursuing health system partnerships, and completing
tuck-in acquisitions. We de-levered our balance sheet by over half a turn of leverage during 2016 and I anticipate that we can
also deleverage in 2017, particularly in the second half of this year when we will have already completed the majority of our capital
spending.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I continue to believe that with RadNet's
model, characterized by geographic concentration, multimodality approach, health system partnerships, and capitation, ideally position
us for the changing landscape of healthcare. Regardless of what happens with healthcare on a legislative level, the practical economics
of the rising cost of healthcare in this country will re&#9;quire change and new payment models, models that address population
health and risk-taking rather than the traditional fee-for-service approach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RadNet has always been on the forefront
of entrepreneurial payment models, business structures, and partnerships, we&rsquo;ve been managing imaging for and taking utilization
risk associated with large patient populations for over 20 years. We have established key health system partnerships on both coasts
under a variety of operating financial structures, with preserved (phon) related business opportunities, such as radiology software,
in-patient staffing, teleradiology, and breast disease management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We've grown to be the largest provider
of outpatient imaging in all of our core markets. I believe that the great efforts associated with creating all of this has provided
us with the background and experience necessary to be successful in the changing future landscape of the healthcare delivery system.
I look forward to updating all of you on our progress as the year progresses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator, we are now ready for the question-and-answer
portion of the call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. If you'd like to ask a question
during today's call, please press star, then one on your telephone keypad. If you are using a speakerphone, please make sure your
mute function is turned off to allow your signal to reach our equipment. Once again, please press star, one at this time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We'll take our first question from Brian
Tanquilut with Jefferies. Please go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hey. Good morning, guys. Congrats; pretty
strong quarter. Howard, first question for you; so, on that last point that you just made, as we think about health systems and
what we're seeing on the radiology side, right&mdash;I mean you've got Envision (phon) and you've got MEDNAX (phon) both trying
to acquire and win contracts from the hospitals, and then you guys are obviously trying to do your joint ventures, I mean what
is the decision process from a hospital's perspective to either outsource a contract to one of those guys or JV with you, and what
is your pitch in order to make the JV structure a more attractive proposition for a hospital's CEO?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Morning, Brian. Well, our pitch isn't so
much to the hospital from an in-patient standpoint. Our pitch to the hospitals are really what they need to be focused on in terms
of larger population health management and how imaging is really the gateway for so many diseases today, particularly those that
lend themselves well to the screening processes. So, while I am quite well aware of the activity going on in the in-patient space
between or amongst the people that you mentioned, MEDNAX, Envision, Team Health is another, etc., that model is a little less attractive
to us given that our focus is primarily outpatient business, number one; number two, the long-term models that I see are going
to be favoring more of the ambulatory and outpatient providers than they are in-patient, as the efforts to ramp down hospital utilization
by reducing the length of stay and having alternative systems to manage patients before they get to the hospital, I think, continues
to put pressure on hospital systems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, our focus will be not necessarily on
what is in the best interest of a particular hospital or radiology group, but how does that hospital or health system position
itself in a marketplace that needs to have a greater reach for its services than just those provided on its immediate campus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All right. Just a follow-up. Sorry, go
ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I was just going to add, Brian, that there's
been a multi-decade migration of business that's been leaving the hospitals in favor of ambulatory providers, whether that's imaging,
laboratories, surgery centers, physical therapy, you name it. Anything that can be done outside the four walls of a hospital, these
days is migrating towards the outpatient players, and so what we've recognized is that the hospitals who are forward-thinking have
been seeing this migration and they're looking at ways and mechanisms where they can recapture some of that outpatient business.
Instead of trying to fight that trend, how do they participate in the trend? So those forward-looking hospitals have approached
us or we've approached them in our markets and are looking at ways that they can now participate in that growth of the ambulatory
practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">They also recognize that a lot of these
patients who are very sick will ultimately find their way into the hospital through surgeries and other services that they provide
on an in-patient basis, so they look at these outpatient ambulatory operations as kind of theater systems, ultimately for their
hospitals. From our standpoint, we like it a lot because it takes one of our competitors, which tends to be the local hospitals,
out of commission or we join forces with one of our competitors for the outpatient business, and many of these hospitals are health
systems with whom we're partnering, have acquired and been more aggressive over the last few years in acquiring physician practices
and other operations outside of their four walls that can be tremendously valuable referral sources into our outpatient imaging.
We hope that once we join forces with a local hospital, then the outreach that they have in the community will help to drive our
volumes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No. That makes a lot of sense. Dr. Berger,
one thing that we're hearing reading trade industry regs and just talking to physicians, is artificial intelligence getting into
the radiology space. So, what are your views in terms of the future of radiology and how technology plays into it, whether it's
a risk or an opportunity?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think it's both, actually, risk and opportunity,
not so much risk for RadNet but risk for radiologists that are resistant or cannot adapt to these changes. What I like to stress
when I meet with people regarding this subject is that artificial intelligence or cognitive learning or machine learning&mdash;whatever
term you want to use&mdash;I think is perhaps more important in radiology than it may be in any other specialty. The reason I say
that is that you have to look deeper into what's happening inside radiology from a technology standpoint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As more and more of the equipment becomes
increasingly sophisticated and capable of generating in shorter periods of time numerous more images, it is becoming increasingly
difficult for radiologists to keep up the productivity and the quality of imaging that the enormous amounts of data produced by
these pieces of equipment&mdash;let me give an example.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the transition from 2-D to 3-D mammography,
the amount of data that the 3-D breast tomography systems are capable of generating are somewhere between 17 and 20 times the amount
of conventional 2-D mammography. What's really driving that are the enormous numbers of additional images produced. I could make
that same comment with MR and with CT, as the number of seat slice scanners goes up for the CT scanners&mdash;what used to be single
slice and now you're talking about 256, 512 slices&mdash;the amount of data and the ability of the human eye to go ahead and look
at each one of these images and detect the slight abnormalities that might be seen become increasingly difficult, not only for
the average radiologist, but also tend to slow them down and become quite fatiguing over the period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, I look at artificial intelligence being
able to sift through these enormous amounts of data and identify the pertinent images that might require further evaluation by
the radiologists, allowing them to be more selective, and at the same time, letting the artificial intelligence give its own interpretation
of what the potential differential diagnosis might be that a radiologist can then use when he does his consulting work with the
referring physician.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, I don't believe artificial intelligence
will replace radiologists. I think it will enhance all of our ability to make everybody in the system more efficient, more accurate,
and in the case of RadNet, more productive in terms of how it's able to manage the large numbers of patients that we expect to
continue to see coming through our centers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No. I appreciate that comment. Mark, last
question for you; so, as we think about EBITDA progression for the year, how should we think about the cadence of EBITDA as we
think about Q2, Q3, Q4? Then also, I noticed that the capitated revenue has been pretty stable at sort of $27 million, $28 million
range. I mean, is there anything that you would call out there? Then how do you foresee that growing in the future?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sure. Sure. So there's a natural seasonality
to our business where first quarter is usually the weakest in terms of volume and profitability given that most of our costs are
fixed costs. We see that the second and third quarter, the summer months, tend to be stronger. Fourth quarter, depending upon where
the holidays fall, whether they fall in the middle of the week or towards the end or the beginning of the week, and depending upon
what the weather situation is, if there's an early and bad winter, severe winter on the East Coast, can affect our results. But
we usually see second and third quarter being our strongest quarter of the year, although we have seen very strong fourth quarters
in the past.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This seasonality has changed over the last
10 to 15 years, since I've been in the business. It used to be that the first quarter&mdash;was strong in the fourth quarter because
of the holidays and the winter was weak, but what's happened, we've seen, is that there's been a pretty steady migration of patients
going into these higher deductible health plans, which has caused them to, at the end of a year, try to scramble and get any types
of services done that are elective or that could otherwise be delayed. They want to get that done before their deductible resets
at the beginning of the year. Then once the beginning of the year comes on, they've either had some of those services, so they
don't need them, or there's kind of a psychological effect where people don't want to start blowing through their deductibles until
they really have to, so just delay and delay and delay until they suddenly start using their deductibles. So, we've seen a lighter
first quarter typically than in the past, and that continues to be the case.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The second part of your question, Brian
was?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitation revenues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitation, yes. I mean, we did see some
growth in capitation. Our capitation revenue quarter-over-quarter was up $2 million, about half of which was based upon greater
enrollments in these capitation contracts. Remember, we're getting a per member, per month fee for these commercial and Medicare
advantage lives, and so as enrollment changes, that per member, per month fee goes up or down. So we have seen some growth in enrollment,
which is nice, and that's basically the typical growth here that we're seeing in managed care in California. Then half of that
was from pricing increases. So we've got $1 million of that $2 million were from price increases that have happened over the last
12 months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Got it. All right. Thanks, guys.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Brian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moving on, we'll take our next question
from Mitra Ramgopal with Sidoti. Please go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hi. Good morning. First just a few questions
regarding the exit from Rhode Island. I was wondering if you could give us a sense as to the revenue from the five locations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sure. The revenue from the five locations
was about $6.5 million to $7 million on an annual basis and the amount of volume that we were talking about from those five locations
was about, I believe about 75,000 exams per year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Thanks. Can you talk a little about
maybe the competitive environment? You mentioned an operator was looking to expand there and so you sold or&mdash;are you seeing
other operators in some of the other geographies you're in right now or expanding?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes. In all the geographies that we remain
providing our services, there are opportunities to expand. In our five core markets&mdash;California, New York, New Jersey, Delaware,
and Maryland&mdash;we are already the largest outpatient imaging provider in each of those markets and we continue to see smaller
operators desirous of becoming part of either the RadNet operation or perhaps finding it too difficult for them to continue themselves
and closing shop. So, we were not particularly interested in staying in the Rhode Island market since we couldn't elevate our presence
in that market to a similar position, and rather than invest more capital in a market where we were not going to be the dominant
player, we felt it better to exit that market and be able to redeploy that capital into our existing markets where we have greater
size and leverage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Thanks, for the color there. Just
on the pricing side, clearly you're seeing some nice initial success in terms of the 3-D mammography and you mentioned you've got
some pricing in terms of with auto (phon) payors. I know you talked about the upcoming CMS proposals, etc., but it seems like at
least from a pricing standpoint, it's pretty favorable for you right now?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Well, yes; I think it is. I think it's
favorable more because of the position that we've been able to establish in our markets where other than, let's say, Medicare,
which is controlled by CMS, we're able to go back to individual payors and negotiate different reimbursement rates, and there's
hardly ever been a case where we didn't go back and get some additional benefit moving forward. But I think that's more, again,
of not necessarily an industry-wide phenomena, it's more of a testimonial to the RadNet strategy where we have such an important
seat at the table that we can have these conversations and try to stress the importance of making certain that reimbursement is
reasonable and equitable for us and how much the payors can actually save by putting plan design together or marketing strategies
with us that move patients out of the hospital systems, which typically cost the patient and the payors three to four times what
it would be in a freestanding outpatient facility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, I think I'd like to give credit to
the entire RadNet Team in terms of its execution of the strategy that has made this possible. I don't think that the average imaging
center operator can simply walk into a payors' offices and expect to get increase in his reimbursement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good. Thanks. That's great. Then finally,
again, I know we're pretty early still in terms of talks about healthcare reform, but I don't know if you could kind of give us
a sense of how much you think the Affordable Care Act might have helped you, and did you see early&mdash;it being fairly neutral
for your business in terms of any changes in terms of Obama Care?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes. Well, I think the primary benefit
from the ACA was really here in California. I think it has been negligible in the other markets that we're in and I think that's
just a matter of demographics. Here in California, and as we've seen with at least some of the preliminary information regarding
the repeal, replace&mdash;I'm not certain what it's going to be in its final form of the ACA&mdash;but in California, so many of
the uninsureds have been opting out for either the exchanges here or other types of plans that the payors here have created. I
don't believe that the state is going to shirk away from its opportunity and the benefit of having these people insured. So, whatever
changes may shift, may occur, could wind up shifting responsibly from the Federal Government to the state, and I believe the California,
because it's in a much better economic position than it was, let's say, five years ago, will be very responsible for making certain
that these people who have now entered into the health system, which is probably statewide somewhere between 1.5 million to 2 million
people don't filter back out into the uninsured marketplace, which costs the system far more money than it does to have them properly
insured.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Thanks again for taking the question.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You're welcome.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Mitra.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Once again, if you'd like to enter the
question queue, that is star, one on your telephone keypad. We'll take our next question from Ed Kressler with Angelo Gordon. Please
go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Edward Kressler:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good morning. Thanks for having the call.
Real quick on cap ex, just trying to get a sense in terms of the cadence through 2017. Q1 was a pretty heavy number, so I guess
about half of your guidance is already spent. Just wanted to get a sense in terms of where that's going. I know Dr. Berger had
made some commentary regarding equipment for 3-D mammography and I was wondering if it's going there. Then what's kind of a more
normalized run rate number for cap ex as the business kind of moves past this fish bowl that we've been in? Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Well, our guidance for cap ex is $55 million
to $60 million for the year. In the first quarter, as you've seen, we spent about $35 million. So, we're very comfortable with
that range, but in and of itself, that would tell you that over the remainder of the year we don't anticipate spending more than
about $25 million over the remaining three quarters here. This is a fairly typical pattern for the Company over the last several
years where we begin projects at the end of the year and the bulk of our spending occurs in that first quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, as Mark alluded to in his remarks,
the fact that there will be a significant lower spending primarily in the third and fourth quarters, should allow us to accumulate
more cash and continue de-levering our balance sheet. So, where that money is being spent is a broad spectrum; some of it is for
a couple of new facilities that we're building here, one on the East Coast and one on the West Coast; some of it for expansion
in the East Coast for our Breastlink initiative in New York; some of it will be for continued investment into the 3-D mammography;
and some of it will be the continued upgrading of equipment, particularly in the x-ray area where the reimbursement from Medicare
will decrease if you don't make a transition into the more sophisticated digital x-ray technology, which we began last year and
will finish off this year to avoid any kind of reimbursement reductions that are going to take place for people who haven't made
the transition starting in 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So I don't think there's any one area where
we're going to be more heavily spending than others. Some of the spending will be maintenance cap ex, as always, but a good part
from this point forward will also be for growth cap ex, particularly as it relates to 3-D tomography and our Breastlink initiatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Edward Kressler:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any sort of guidance in terms of what run
rate maintenance cap ex will be?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally speaking, we're comfortable that
about half of our cap ex is maintenance and half of it is growth cap ex. That distinction is one that require a longer explanation,
but much of what we do when it comes to equipment, like CT scanning and MR scanning, as actually growth cap ex, as well as maintenance
cap ex because the newer equipment allows us to do a greater breadth of procedures and also to increase capacity by reducing scan
times. So, when we have opportunities like that, and particularly when we have high demand and some backlog issues, you'll see
a lot of our spending will come along those lines because, overall, that enhances not only upgrading our facilities and keeping
our competitive advantage in the marketplace, but also enhancing revenue opportunities. But roughly speaking, I think a 50/50 mix
is accurate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Edward Kressler:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. That's great. Thank you so much.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Once again, that is star, one if you have
a question or comment on today's call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It appears there are no further questions
at this time. I would like to turn the call back over to Management for any additional or closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, M.D.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Operator. Again, I would like
to take the opportunity to thank all of our Shareholders for their continued support and the employees at RadNet for their dedication
and hard work. Management will continue its endeavor to be a market leader that provides great services with an appropriate return
on investments for all Stakeholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you for your time today and I look
forward to our next call.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Once again, that does conclude today's
conference. Thank you for your participation. You may now disconnect.</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ \ #P  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" #V D # 2(  A$! Q$!_\0
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MMBWL[:U7;;V\4(](T"_RH ^?%\-:_= -;Z7?R ]"(FQ4B^ O&+_-#I=W']9
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1124 +4-Q=16R;I&QZ =345U>B$%4^9_T%8\Q>5R[L6)[F@!+[4KBZ
MRBDQQ_W1U/U-93I5_P IG8*JEF/0"M*ST1 0]U\Q[(.GXT 8%MI5S?MB&/Y>
M[MP!6Y9>&+*WP]Q_I$G^U]T?A6RJJBA5  '0 4Z@!JHJ*%10JCH ,"G444 %
M%%% !1110 4444 %%%% !1110!0O-'L[R87#1F*Y4?+<0G9(/^!#J/8Y%20"
M[@81SL+A.TH&UO\ @0Z?B/RJW10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %5+FYQE(SSW-/N)<91>
MO<U3(XH @9:([9YWVH/J3VJQ' TS8' [FM".-8D"J,"@".VM([9?E&6/5CUJ
M>BB@ HHHH **** "BBDH 6BDS10 M%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !44
MTFP8'4T]VVJ2:JL2Q)/4T ,-*D9D;:.G<TH4L0!UJU&@1<#\30 J(J*%4<4Z
MBB@ HHHH *2H;N\M[&!I[F58XU[D]?I7 ^(?'%]<!H-*!M8NAE(^=OIZ?SH
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M &D'#_5<'VH W:*CAGBN(EDB<.C="*DH **** "BBB@ HHHH **** "BBB@
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M@9.3@=:6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%SU'IGO^-=0*6J,RI87RWD9W(8YEX>,]0:MU6N;7>XGB^69.X_B'H:EBD\Q
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MK'[-&))!^\8?]\BN>\(:=Y@-U(/DCX7W;_ZU=?0 4444 %>=?&/_ ) NG_\
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M=KS\1\9]-EG^[KU8Y(I),B.-W(&3M4G IO<CH1U![5W_ ,'_ /D8[S_KT/\
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MC#_R+5I_U]C_ -!:O':]B^,/_(M6G_7V/_06KQVO/Q'QGTV6?[NO4] ^#_\
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M^NB?^S5Z33>XEL%%%%(85E^)O^1;O_\ KB:U*R_$W_(MW_\ UQ- 'DU&E_\
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M"VD'^N@+-_P/)_K6&'C>+/0S.KRU8+MJ> CD5ZA\'+X;M2T]B<D),H_\=/\
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MQN^]TKOO^$@T?_H)6W_?P5Y'10!ZV?$6C>8D?]IVV^1MJ+Y@RQ]!6C7A;?\
M(:TC_K\3_P!"%>Z4 +67XF_Y%N__ .N)K4K+\3?\BW?_ /7$T >34:7_ ,CQ
MH7_7<44:7_R/&A?]=Q30F>VT444AB5SEYX&TJ[N7G!F@+DDK&PQGU&1Q71G@
M&N6/Q TL$C[/=<''W5_QH T/#_A;3?#BRFR1WEG.99I6W.WMGT]JVJY_0/&-
MAXBU&YL;2&X22V7<YE4 $9QQ@UHZOJL.C6)O)T=T#!<)C/- %^BN0F^(VF0P
MO*;6Z(09( 7_ !I/^%C6$EI'-!9W+.XR8WPNWZF@#L**X=_B.RG*Z267N//
M/X<5N^'?%6G>)(I/LK/'/#_K;>48=/\ $>] &W114%W>6]A;/<W4JQ1)U9J
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M%PU[+\O^XO _7-=[7HI621\Q4GSSE+NSSCQ]_P A]/\ K@O\S7'ZE_R#9_\
M<KL/'W_(?3_K@O\ ,UQ^I?\ (-G_ -RF9GKG@S_D3M)_Z]4_E5?QQI_VS0C.
MHS):MY@_W>A_S[58\&?\B=I/_7JG\JV)HEGA>*091U*L/4&@2V/%:*L7]FUA
M?SVC]87*_4=C^55Z!FW\+O\ D:]9_P"N*_\ H5>I5Y;\+O\ D:]9_P"N*_\
MH5>I4V)'$_$7[MA]7_I7$5V_Q%^[8?5_Z5Q%(9TGPG_X_=<_ZZ)_[-7I->;?
M"?\ X_M<_P"NB?\ LU>DTWN);!1112&%9?B;_D6[_P#ZXFM2LOQ-_P BW?\
M_7$T >34:7_R/&A?]=Q11I?_ "/&A?\ 7<4T)GMM%)1FD,&^Z?I7BC?ZQO\
M>/\ .O:V^Z?I7BC?ZQO]X_SH V?A=_R->K_]<1_Z$*[#QU_R+;_]=4_G7'_"
M[_D:]7_ZXC_T(5V'CK_D6W_ZZI_.FQ(\NOO^/&?_ '#7I/PS_P"1&LO]Y_\
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M-:-=Y\TMBEJ]H+[1[VUQDS0.@'N0<5\U[2ORMU'!KZ@->(ZK\-_$C:M=M:6
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MJ_\ PANO?\^8_P"_B_XT?\(;KW_/F/\ OXO^- #KOX@:Y!:2RH;?<JY&8O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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@0 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  B P8# 2(  A$! Q$!_\0
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M.OIT0^,O')'_ ",FH#L?W5GQGM_Q[=QR.G\.>#6L=./>(?@J\?D/8GFHSII
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M-%T+PGHNF:3]DTXSW\]HMU']8C5T)!R#@@[MW(Q@\$ 8&#SGIDDD 9#EU8
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MSQX&O?A#\#OA?\.-7DAG\2>&_"6GQ^,;ZVN7OH-3\<ZJTFM>-M7749+>UFU
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M/56EJM[N_JM'K:UOGH:+.%HN:D[62BN79<WN_'M:<DK7E96=E=OY5\+?"_\
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M-]%KLM#XR^#G[/WQ*^&_BGX2^)]?'A.2Q^'VC_MGG75M?$<\CM/\;?C#IWQ
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MU?J+EHNRYZ:2_OQ_^6,H"Q3IA.O=AV_X#GT!QG(S[4TV,62=F<@#.1V.1QM
M[L"><@GC@&M'[9;?\][/_P "(O\ XJC[9;?\][/_ ,"(O_BJKGGYO_MVI_\
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MS\Q*$/Y(;/[$/Y7_ '1?[4U,=-1OQ_V]W'_QRD.JZIQ_Q,K_ )//^F7'H?\
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M^_\ TTHHJ;OVBU?P]W_*_,:IPM?DA>TM>2%_CAUY+_B(=3U+</\ B87WWO\
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M.:4(<S]R'3[$.W^$/[2U'_G_ +W_ ,"I_P#XY2#4M1Q_Q_WO4_\ +U/ZD?\
M/3TXHHJ[ON_O?^9I0A!R=X0?N]80?7S@Q?[2U'_G_O?_  *G_P#CE']I:C_S
M_P![_P"!4_\ \<HHHN^[^]_YG3[.G_S[I_\ @NG_ /(!_:6H_P#/_>_^!4__
M ,<H&HZA@_Z=>=,_\?4_7(Y^_114R;L]7][)G3I\LOW=/;_GW3\O[@?VEJ/_
M #_WO_@5/_\ '*/[2U'_ )_[W_P*G_\ CE%%9-O35[+J_/S'&G3Y5^[I[?\
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"_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
